Previous close | 258.16 |
Open | 257.36 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 252.91 - 258.18 |
52-week range | 176.80 - 411.53 |
Volume | |
Avg. volume | 944 |
Market cap | 19.535B |
Beta (5Y monthly) | 1.66 |
PE ratio (TTM) | 0.29 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
TEMPE, Ariz. & SAN JOSE, Calif., May 22, 2024--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsi
TEMPE, Ariz., May 13, 2024--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Techno
TEMPE, Ariz., April 26, 2024--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $150 million of Align’s common stock through open market repurchases under Align’s $1.0 billion stock repurchase program that was approved by Al